Beviljade anslag 2019-2021

Oktober 2021
  • Maria Lindh, Södra Älvsborgs Sjukhus
    Behandlingseffekt och läkemedelsval hos kvinnor som lever med HIV i Sverige
    200.000 kr
  • Robert van Domselaar, Karolinska Institutet
    NK celler för indirekt shock-and-kill-strategi vid behandling av HIV-1
    200.000 kr
  • Rafael Cena Diez, Karolinska Institutet
    Anti-HIV-1 dipeptide WG-am: mechanism and effectivity against drug resistant isolates
    200.000 lr
  • Stina Malmström, Region Västmanland
    Hiv och lymfom 
    200.000 kr
  • Mathias Franzén Boger, Karolinska Institutet
    Safety evaluation of a microbicide compound against HIV infection 
    200.000 kr
  • Vilde Kaldhusdal, Karolinska Institutet
    Identifying molecular signals in the genital mucosa of women using the hormonal contraceptive DMPA 
    200.000 kr
Mars 2021
  • Klara Sondén, Karolinska Institutet   
    Travel to subtropical and tropical areas as indicator of HIV risk – a study of febrile patients
    100.000 kr 
  • Amanda Arnell, Göteborgs Universitet
    The use of artificial intelligence (AI) in cervical cancer screening in HIV+ women
    100.000 kr  
  • Piotr Nowak, Karolinska Institutet
    The impact of microbiome and HIV-reservoir on immunological response to vaccination against SARS-CoV
    100.000 kr 
  • Marion Humbert, Karolinska Institutet
    T cell immunity in perinatally HIV-1 infected children undergoing antiretroviral treatment
    100.000 kr 
  • Elin  Jones, Karolinska Institutet
    Hiv-behandling av gravida kvinnor och dess inverkan på immunförsvaret och barnets utveckling
    200.000 kr
Oktober 2020
  • Peter Thelin Schmidt, Ersta Sjukhus
    Ny metod för skonsam behandling av anal precancer
    200.000 SEK
  • Peter Svensson, Karolinska Institutet
    Reactivation potential of the latent reservoir after long-term ART and its importance for HIV cure
    200.000 SEK
  • Oscar Kieri, Karolinska Universitetssjukhuset
    Characterization of the HIV gut reservoir and its changes during ART
    Summa: 100.000 SEK
  • Oskar Olsson, Lunds Universitet
    Aktivetet av indoleamin-2,3- diogyxenas som biomarkör för tuberkulos hos personer med HIV
    Summa: 200.000 SEK
  • Gabriella Edfeldt, Karolinska Institutet
    Host-bacteria characterization to unravel links between vaginal dysbiosis and HIV risk
    100.000 SEK
  • Martin Kåberg, Karolinska Institutet och Sprututbytet i Stockholm
    HIV among people who inject drugs (PWID) in Stockholm - Prevalence, Incidence and Treatment Outcome
    200.000 SEK
  • Shilpa Ray, Karolinska Institutet
    Are microbiome changes responsible for the weight gain in individuals treated with dolutegravir?
    100.000 SEK
Mars 2020
  • Gaetano Marrone, Karolinska Universitetssjukhuset, Infektionskliniken och Klinisk Mikrobiologi
    HIV and Ageing - Prevention of coronary artery disease among People living with HIV    
    200.000 kr
  • Rafael Cena Diez, Karolinska Institutet, Labmed
    Are there HIV subtype differences in drug resistance to integrase strand transfer inhibitors, INSTI?       
    200.000 kr        
Oktober 2019
  • Frideborg Bradley, Karolinska Institutet
    Delineating molecular mechanisms for how the genital microbiome affects the cervical mucosa
    200.000 kr
  • Katarina Johansson Århem, Karolinska Institutet och Karolinska Universitetssjukhuset Infektionskliniken
    Assessing mental health and quality of Life in Ugandan adolescents. Are we reaching the 4th 90 goal?
    200.000 kr
  • Annelie Tjernlund, Karolinska Institutet
    Spatial visualization of mucosal immune protection against sexually transmitted HIV
    200.000 kr
  • Anna Kågesten, Karolinska Institutet
    Unintended pregnancies and contraceptive use among HIV-positive postpartum women in urban Tanzania
    200.000 kr
  • Lisa Norrgren, Göteborgs Universitet
    Time Preferences and Medical Adherence: A Study of HIV Positive Patients in Sweden
    100.000 kr
  • Maria Röhl, Karolinska Institutet
    A novel concept of safety evaluation of a rectal microbicide in healthy volunteers
    200.000 kr

Mars 2019
  • Christina Carlander, Karolinska Institutet
    Employment status of people living with and without HIV in Sweden
    200.000 kr
  • Olof Elvstam, Lunds universitet
    Is low-level viremia during ART associated with increased risk of death and serious non-AIDS events?
    200.000 kr
  • Jaran Eriksen, Karolinska Institutet
    Effects of co-administration of antiretroviral treatment and anticonvulsants on clinical outcomes
    200.000 kr
  • Marcus Buggert, Karolinska Institutet
    Defining viral control mechanisms of resident memory T cells in HIV-infected lymphoid tissues
    200.000 kr
  • Maike Sperk, Karolinska Institutet
    Omics study of persons on preexposure prophylaxis
    200.000 kr

Alla beviljade anslag sedan 2002 i .pdf